Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000062

Chief Medical Officer sold 231,716 shares at an average $12.92 ($2,994,401)

  • Chief Medical Officer acquired 231,716 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2023-08-10 Option exercise +74,625 $0.54 $40,298 74,625 D
Rodman David Malcom Chief Medical Officer 2023-08-10 Sale −74,625 $13.16 $982,065 0 D
Rodman David Malcom Chief Medical Officer 2023-08-11 Option exercise +80,909 $0.54 $43,691 80,909 D
Rodman David Malcom Chief Medical Officer 2023-08-11 Sale −80,909 $12.81 $1,036,444 0 D
Rodman David Malcom Chief Medical Officer 2023-08-11 Option exercise +76,182 $1.08 $82,277 76,182 D
Rodman David Malcom Chief Medical Officer 2023-08-11 Sale −76,182 $12.81 $975,891 0 D
Derivatives
Rodman David Malcom Chief Medical Officer 2023-08-10 Option exercise · Stock Option −74,625 166,202 D
Rodman David Malcom Chief Medical Officer 2023-08-11 Option exercise · Stock Option −80,909 85,293 D
Rodman David Malcom Chief Medical Officer 2023-08-11 Option exercise · Stock Option −76,182 228,548 D
Open-market sales · 231,716 sh · avg $12.92 · $2,994,401
Loading xslF345X05/wf-form4_169179547763057.xml…